N91115-2CF-05 (SNO-6): A Phase 2, Randomized, Double-Bli

Project: Research project

Project Details

Description

N91115-2CF-05 (SNO-6): A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of N91115 to Evaluate Efficacy and Safety in Patients with Cystic Fibrosis who are Homozygous for the
StatusFinished
Effective start/end date9/15/1512/31/16

Funding

  • NIVALIS THERAPEUTICS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.